Inventor
Jason Michael GEHRKE
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides29%
C12NMicroorganisms or enzymes29%
C12YEnzymes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
A61KPreparations for medical, dental or toiletry purposes8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
PatentTitleYear
12,594,301Compositions and methods for treatment of liquid cancers202612,454,694Compositions and methods for improving base editing202512,286,641Methods for increasing efficiency of nuclease-induced homology-directed repair202512,133,884Methods of substituting pathogenic amino acids using programmable base editor systems202411,725,228Methods for detecting site-specific and spurious genomic deamination induced by base editing technologies202311,326,157Base editors with improved precision and specificity202211,155,803Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to BEAM THERAPEUTICS INC (4)· patent assignee history
2021–2026Based in US· patent location history
2022–2025Patents assigned to MASSACHUSETTS GEN HOSPITAL (3)· patent assignee history
2026Patents assigned to UCL BUSINESS LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BEAM THERAPEUTICS INC | 4 | 2021–2026 |
| MASSACHUSETTS GEN HOSPITAL | 3 | 2022–2025 |
| UCL BUSINESS LTD | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2021–2026 |